ACADIA Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 21 analysts polled by S&P Global, ACADIA Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $33.85. The average 1-year stock price forecast is 14.75% higher than the current stock price, while the lowest is $17 (-42.37%) and the highest is $49 (+66.10%).

Price Target: $33.85 (+14.75%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$17	$33.85	$36	$49
Change	-42.37%	+14.75%	+22.03%	+66.10%

Analyst Ratings

The average analyst rating for ACADIA Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	12	12	12	12	12	12
Buy	4	4	4	4	4	4
Hold	4	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	21	21	21	21	21	21

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Malcolm Hoffman BMO Capital	BMO Capital	Buy Maintains $36	Buy	Maintains	$36	+22.03%	Aug 18, 2026
Ashwani Verma UBS	UBS	Buy Reiterates $45 → $49	Buy	Reiterates	$45 → $49	+66.10%	Aug 17, 2026
Sumant Kulkarni Canaccord Genuity	Canaccord Genuity	Buy Maintains $36	Buy	Maintains	$36	+22.03%	Aug 13, 2026
Ami Fadia Needham	Needham	Buy Reiterates $38 → $41	Buy	Reiterates	$38 → $41	+38.98%	Aug 12, 2026
Sean Laaman Morgan Stanley	Morgan Stanley	Hold Reiterates $26 → $27	Hold	Reiterates	$26 → $27	-8.47%	Aug 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.27B

from 1.07B

18.73%

from 1.07B

Revenue Next Year

1.43B

from 1.27B

12.51%

from 1.27B

EPS This Year

0.60

from 0.83

-27.87%

from 0.83

EPS Next Year

0.89

from 0.60

48.45%

from 0.60

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	484.15M	517.24M	726.44M	957.80M	1.07B	1.27B
Revenue Growth	9.60%	6.83%	40.45%	31.85%	11.87%	18.73%
Operating Income	-170.44M	-223.60M	-73.38M	84.28M	104.81M	107.24M
Net Income	-167.87M	-215.98M	-61.29M	226.45M	391.00M	105.57M
EPS	-	-	-	-	0.83	0.60
EPS Growth	-	-	-	-	-38.99%	-27.87%
Forward PE	-	-	27.40	35.90	40.38	49.28
Free Cash Flow	-65.26M	-34.96M	28.44M	270.08M	-153.66M	117.10M
No. Analysts	-	-	-	-	-	20

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.3B
Avg	1.3B
Low	1.3B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	21.3%
Avg	18.7%
Low	17.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	0.72
Avg	0.60
Low	0.50

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-13.2%
Avg	-27.9%
Low	-39.7%